Role of the alarmin S100A9 in the pathogenesis of heart failure with preserved ejection fraction

1 September 2024 (07:55 - 08:50)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Ms Isabel Marie Voss

Berlin Institute of Health Center for Regenerative Therapies, Berlin (Germany)

7 More presentations in this session

Presentation thumbnail

Identification and validation of circulating microRNAs as biomarkers for heart failure with preserved ejection fraction

Doctor L. Zhang (Beijing, CN)

Abstract Slides Video

Presentation thumbnail

Characterization and progression of heart failure with preserved ejection fraction in SDT fatty rats.

Doctor R. Assaly (Escalquens, FR)

Abstract Slides Video

Presentation thumbnail

Prognostic impact of left atrial reverse remodeling in patients with ADHF-HFpEF regardless of atrial fibrillation -PURSUIT-HFpEF Registry-

Doctor T. Kondo (Osaka, JP)

Abstract Slides Video

Presentation thumbnail

Age-predicted maximal heart rate reserve as an alternative prognostic parameter in patients with heart failure with preserved ejection fraction -insights from PURSUIT-HFpEF registry-

Doctor M. Okada (Osaka, JP)

Abstract Slides Video

Presentation thumbnail

Gender differences in the evolution of echocardiographic HFpEF characteristics through age deciles: is menopause an inflection point?

Doctor K. George (Adelaide, AU)

Abstract Slides Video

Access the full session

Session thumbnail

HFpEF: data from animal studies and registries

The Event

Event poster

ESC Congress 2024

1 September 2024 07:55 CET

You may be interested in

Congress Presentation

Targeting the innate immune system in heart failure

Congress Session

Basic and Translational Late-Breaking Science session

Congress Session

Inflammation in heart failure

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources